Amir Bagheri Selected Research

Cerebral Malaria

1/2017

Controlled release of artemisone for the treatment of experimental cerebral malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amir Bagheri Research Topics

Disease

1	Sarcopenia 01/2022
1	Insulin Resistance 01/2022
1	Autosomal Dominant Rhegmatogenous Retinal Detachment 01/2022
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Nervous System Diseases (Neurological Disorders) 03/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Infections 01/2017
1	Cerebral Malaria 01/2017
1	Cysts 12/2013
1	Body Weight (Weight, Body) 12/2013
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2013

Drug/Important Bio-Agent (IBA)

1	oxidized low density lipoproteinIBA 01/2022
1	Branched-Chain Amino AcidsIBA 01/2022
1	Coffee FDA Link 01/2022
1	EnzymesIBA 10/2021
1	MagnesiumIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2019
1	A-factor (Streptomyces)IBA 01/2018
1	PolymersIBA 01/2017
1	artemisoneIBA 01/2017
1	Bee Venoms (Bee Venom)IBA 12/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2013
1	Interleukin-6 (Interleukin 6)IBA 12/2013